Abstract | OBJECTIVES: DESIGN: Randomized single-blind controlled trial. SETTING: Tororo, Uganda, an area of high-level malaria transmission. PARTICIPANTS: INTERVENTIONS: OUTCOME MEASURES: Risks of recurrent symptomatic malaria and recurrent parasitemia at 28 days, unadjusted and adjusted by genotyping to distinguish recrudescences and new infections. RESULTS: CONCLUSIONS:
|
Authors | Hasifa Bukirwa, Adoke Yeka, Moses R Kamya, Ambrose Talisuna, Kristin Banek, Nathan Bakyaita, John Bosco Rwakimari, Philip J Rosenthal, Fred Wabwire-Mangen, Grant Dorsey, Sarah G Staedke |
Journal | PLoS clinical trials
(PLoS Clin Trials)
Vol. 1
Issue 1
Pg. e7
(May 2006)
ISSN: 1555-5887 [Electronic] England |
PMID | 16871329
(Publication Type: Journal Article)
|